Related by context. Frequent words. (Click for all words.) 65 Cytokinetics Incorporated NASDAQ CYTK 62 #th Annual Interscience 60 AACR NCI EORTC 60 forodesine 60 Pivotal Phase III 60 phase IIb clinical 60 RegeneRx Biopharmaceuticals Inc. 59 NASDAQ DYAX 59 Phase Ib clinical 59 CROI 59 Molecular Cancer 59 Nasdaq REGN 59 Nasdaq VRTX 59 ASH Annual Meeting 59 Opportunistic Infections CROI 58 NASDAQ ARIA 58 Inc. Nasdaq SGEN 58 NASDAQ NYMX 58 SABCS 58 RGB # 58 Inc. Nasdaq EXEL 57 Preclinical Data 57 Phase 2a clinical 57 Nasdaq DNDN 57 elotuzumab 57 multicenter Phase 57 ILLUMINATE 57 MOZOBIL 57 Pivotal Phase 56 placebo controlled clinical 56 Guanilib 56 Presents Positive 56 NASDAQ AMAG 56 Diabetologia 56 PEG SN# 56 www.labopharm.com 56 Clinical Oncology Annual Meeting 56 CR# vcMMAE 56 ganetespib 56 Inc. Nasdaq IMGN 56 NASDAQ BPAX 56 ALN VSP 56 OXi# 56 tanespimycin 56 Transcatheter Cardiovascular Therapeutics TCT 56 ZFP Therapeutic 56 Gynecologic Oncology Group 56 AZX# 56 Arch Neurol 55 EORTC NCI AACR Symposium 55 AASLD 55 EORTC NCI AACR 55 glufosfamide 55 pharmacokinetic PK 55 Celsion Corporation 55 annual Transcatheter Cardiovascular 55 OTCQX RHHBY 55 Medical Oncology ESMO 55 alvimopan 55 Phase IIa clinical 55 NSABP 55 Metastatic Melanoma 55 Phase 2b clinical 55 Nymox Pharmaceutical Corporation 55 SPIRIT IV 55 placebo controlled clinical trials 55 Amrubicin 55 Oncology ASTRO 54 Azedra 54 Sunesis Pharmaceuticals Inc. 54 Phase 1b trial 54 bicifadine 54 Hana Biosciences 54 ASCO Annual Meeting 54 ALN TTR# 54 Phase III Clinical Trial 54 phase IIa 54 APOPTONE 54 sipuleucel T 54 Phase 1b clinical 54 Phase 1b 54 Inc. Nasdaq DSCO 54 phase IIb 54 deforolimus 54 Lipid Sciences Inc. 54 placebo controlled studies 54 ENDO 54 adecatumumab 54 Lorus Therapeutics 54 Multicenter 54 Arteriosclerosis Thrombosis 54 #:#-# [033] 54 www.syntapharma.com 54 liposomal formulation 54 Am J Epidemiol 54 Gastrointestinal Cancers Symposium 54 Solid Tumors 54 Breast Cancer Symposium 54 Chemokine Therapeutics 54 CTI Nasdaq 54 Cambridge Healthtech Institute